Helle Hjorth Johannesen

Medicin og biovidenskab

1. Positron-Emission Tomography 100%
2. Magnetic Resonance Imaging 89%
3. Electrochemotherapy 84%
4. Pyruvic Acid 70%
5. Neoplasms 68%
6. Fluorodeoxyglucose F18 61%
7. Squamous Cell Carcinoma of Head and Neck 59%
8. 64Cu-DOTATATE 48%
9. Positron Emission Tomography Computed Tomography 45%
10. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 40%
11. Lactic Acid 39%
12. Canidae 31%
13. Radiotherapy 30%
14. Liraglutide 29%
15. Response Evaluation Criteria in Solid Tumors 29%
16. Miniature Swine 28%
17. Tattooing 28%
18. Magnetic Resonance Spectroscopy 27%
19. Diffusion Magnetic Resonance Imaging 27%
20. Glucagon-Like Peptide-1 Receptor 27%
21. Cetuximab 26%
22. Biopsy 25%
23. Electroporation 25%
24. Colorectal Neoplasms 25%
25. Irinotecan 24%
26. Tumor Burden 24%
27. Therapeutics 24%
28. Perfusion 22%
29. Head and Neck Neoplasms 22%
30. Recurrence 22%
31. Stroke 21%
32. Meretoja syndrome 19%
33. Glucose 19%
34. Multimodal Imaging 19%
35. Infarction 17%
36. Fluorine-18 17%
37. Lung Neoplasms 16%
38. Integrins 16%
39. Cerebrovascular Circulation 16%
40. Brain 16%
41. Phase II Clinical Trials 16%
42. Glycolysis 16%
43. Biomarkers 15%
44. Neoplasm Metastasis 15%
45. Fats 15%
46. Clinical Trials 15%
47. Lactobacillus rhamnosus 14%
48. Inflammation 14%
49. Multiparametric Magnetic Resonance Imaging 14%
50. Metabolic Diseases 14%